First Time Loading...

Vivos Therapeutics Inc
NASDAQ:VVOS

Watchlist Manager
Vivos Therapeutics Inc Logo
Vivos Therapeutics Inc
NASDAQ:VVOS
Watchlist
Price: 2.18 USD -12.45% Market Closed
Updated: May 16, 2024

Vivos Therapeutics Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vivos Therapeutics Inc
Gross Profit Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Vivos Therapeutics Inc
NASDAQ:VVOS
Gross Profit
$8.3m
CAGR 3-Years
-7%
CAGR 5-Years
25%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Gross Profit
$4B
CAGR 3-Years
4%
CAGR 5-Years
5%
CAGR 10-Years
1%
Quest Diagnostics Inc
NYSE:DGX
Gross Profit
$3.1B
CAGR 3-Years
-10%
CAGR 5-Years
3%
CAGR 10-Years
1%
CVS Health Corp
NYSE:CVS
Gross Profit
$53.6B
CAGR 3-Years
-20%
CAGR 5-Years
-1%
CAGR 10-Years
8%
Cigna Corp
NYSE:CI
Gross Profit
$25.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Gross Profit
$3.4B
CAGR 3-Years
-16%
CAGR 5-Years
1%
CAGR 10-Years
5%

See Also

What is Vivos Therapeutics Inc's Gross Profit?
Gross Profit
8.3m USD

Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's Gross Profit amounts to 8.3m USD.

What is Vivos Therapeutics Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
25%

Over the last year, the Gross Profit growth was -17%. The average annual Gross Profit growth rates for Vivos Therapeutics Inc have been -7% over the past three years , 25% over the past five years .